Key result
Higher adherence to European Society of Cardiology acute myocardial infarction quality indicators was associated with reduced 30-day mortality.
Why the study?
To compare temporal changes in European Society of Cardiology acute myocardial infarction quality indicator attainment between the UK and Israel.
Does higher attainment of ESC AMI quality indicators improve 30-day mortality in patients with acute myocardial infarction?
Observational (n=21,829)
Yes
Does higher attainment of ESC AMI quality indicators improve 30-day mortality in patients with acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Higher adherence to ESC AMI quality indicators is associated with reduced 30-day mortality, highlighting the value of international benchmarking for quality improvement.
OBJECTIVE: To compare temporal changes in European Society of Cardiology (ESC) acute myocardial infarction (AMI) quality indicator (QI) attainment in the UK and Israel. METHODS: Data cross-walking using information from the Myocardial Ischaemia National Audit Project and the Acute Coronary Syndrome in Israel Survey for matching 2-month periods in 2006, 2010 and 2013 was used to compare country-specific attainment of 14 ESC AMI QIs. RESULTS: Patients in the UK (n=17 068) compared with Israel (n=5647) were older, more likely to be women, and had less diabetes, dyslipidaemia and heart failure. Baseline ischaemic risk was lower in Israel than the UK (Global Registry of Acute Coronary Events (GRACE) risk, 110.5 vs 121.0). Overall, rates of coronary angiography (87.6% vs 64.8%) and percutaneous coronary intervention (70.3% vs 41.0%) were higher in Israel compared with the UK. Composite QI performance increased more in the UK (1.0%-86.0%) than Israel (70.2%-78.0%). Mortality rates at 30 days declined in each country, with lower rates in Israel in 2013 (4.2% vs 7.6%). Composite QI adherence adjusted for GRACE risk score was inversely associated with 30-day mortality (OR 0.95; CI 0.95 to 0.97, p<0.001). CONCLUSIONS: International comparisons of guideline recommended AMI care and outcomes can be quantified using the ESC AMI QIs. International implementation of the ESC AMI QIs may reveal country-specific opportunities for improved healthcare delivery.
No takes yet. Share an insight, caveat, or question.
Zusman et al. (2019) conducted an observational in Acute myocardial infarction (n=21,829). ESC AMI Quality Indicator adherence vs. Lower adherence was evaluated on 30-day mortality (OR 0.95, 95% CI 0.95-0.97, p=<0.001). Higher adherence to European Society of Cardiology acute myocardial infarction quality indicators was associated with reduced 30-day mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: